• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

American Heart Assn.

Philips, AHA, UPMC launch $30m heart-focused venture fund

May 21, 2018 By Fink Densford

Royal Philips (NYSE:PHG) said late last week it is joining with the American Heart Association and UPMC to launch a $30 million heart-focused collaborative venture capital fund. The newly formed Cardeation Capital fund will support innovation in products for treating heart disease and stroke care. The fund will be managed by Aphelion Capital, with each major […]

Filed Under: Business/Financial News, Cardiovascular, Wall Street Beat Tagged With: American Heart Assn., Philips, UPMC

Stryker touts AHA, ASA updated guidelines based on Dawn thrombectomy trial results

January 29, 2018 By Fink Densford

Stryker (NYSE:SYK) said last week that the American Heart Association and American Stroke Association updated guidelines on ischemic stroke based on evidence from the company-sponsored Dawn trial of its Trevo thrombectomy device. The new recommendations shift the treatment window from six to 16 hours and state that treatment could be a reasonable course of action for up […]

Filed Under: Clinical Trials, Neurological, Vascular Tagged With: American Heart Assn., American Stroke Assn., Stryker

Four major medical associations collab to form Xcertia mobile health app guidance group

December 12, 2016 By Fink Densford

Four major medical associations said today they will group to form Xcertia, a multi-stakeholder collaboration focused on improving mobile health applications. The American Medical Association, American Heart Association, DHX Group and Healthcare Information and Management Systems Society will join together to create the non-profit corporation, which looks to establish and promote best practices for mobile […]

Filed Under: Business/Financial News, Digital Health Tagged With: American Heart Assn., American Medical Assn., DHX Group, Healthcare Information and Management Systems Society, Xcertia

St. Jude Medical’s HeartMate 3 implantable pump beats HeartMate II in pivotal trial

November 16, 2016 By Brad Perriello

The next-generation HeartMate 3 implantable pump St. Jude Medical (NYSE:STJ) acquired when it paid $3 billion for Thoratec last year proved superior to the older HeartMate II device at 6 months in pivotal clinical trial results released today. The Momentum 3 study enrolled more than 1,000 patients for a short-term outcome after 6 months and a longer-term, […]

Filed Under: Cardiovascular, Clinical Trials, Structural Heart Tagged With: American Heart Assn., New England Journal of Medicine, stjudemedical, Thoratec Corp.

Brigham doc wins $75m heart disease research grant

October 6, 2016 By Fink Densford

Boston-based Brigham and Women’s Hospital cardiovascular medicine chief Dr. Calum MacRae won a $75 million heart disease research grant from the American Heart Association to investigate coronary heart disease. The money comes from the One Brave Idea research grant, which was funded by the AHA, Verily Life Sciences and AstraZeneca (NYSE:AZN), with an eventual end goal of […]

Filed Under: Cardiovascular, Research & Development Tagged With: American Heart Assn., AstraZeneca plc, Verily

Irregular heartbeat may be tied to more than just stroke risk

September 8, 2016 By MassDevice

(Reuters) – Atrial fibrillation, a type of irregular heartbeat that’s already linked to an increased risk of stroke, may also be tied to higher risk of heart attack, heart failure, kidney disease and sudden death, according to a new research review. “It was particularly noteworthy that the relative and absolute risk increase for heart failure […]

Filed Under: Cardiovascular Tagged With: American Heart Assn.

AHA: Wearable defib may be alternative to ICD for select patients

March 28, 2016 By Fink Densford

Wearable automatic defibrillators may be a viable alternative to implantable cardioverter-defibrillators in patients at risk for life threatening heart rhythm abnormalities, according to the American Heart Association. The AHA said it recently published an advisory on the use of wearable defibs in its journal Circulation. Light-weight wearable automatic defibrillators are designed to be worn under […]

Filed Under: Cardiovascular, Structural Heart Tagged With: American Heart Assn.

Study shows advantages of mitral valve replacement over repair

November 10, 2015 By MassDevice

(Reuters) —  Patients with severe leakage from the mitral valve of the heart who had the valve replaced had significantly lower rates of recurrence and heart failure two years after the procedure than those who underwent surgical repair, according to data presented on Monday. Mitral valve regurgitation, in which blood leaks backward through the valve […]

Filed Under: Cardiovascular, Clinical Trials Tagged With: American Heart Assn.

UPDATE: Medical societies update stroke guidelines

June 30, 2015 By Fink Densford

A bevy of cardiac medical societies updated their guidelines for stroke treatment yesterday to take into account new devices and technology, including left atrial appendage occlusion devices, stent retrievers and thrombectomy devices. The American College of Cardiology, Heart Rhythm Society and Society for Cardiovascular Angiography and Interventions have updated their guidelines to include the benefits of left […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Vascular Tagged With: American College of Cardiology, American Heart Assn., Heart Rhythm Society, Society for Cardiovascular Angiography & Intervention

AHA/ASA updates stroke treatment guidelines

June 29, 2015 By Fink Densford

The American Heart Association/American Stroke Association said today that it updated its treatment guidelines for patients suffering from ischemic stroke to include endovascular treatments. The decision supports the use of stent retrieval, and other thrombectomy devices, used to remove clots in patients who have obstructions in the large arteries supplying blood to the brain according […]

Filed Under: Cardiovascular, Clinical Trials, Structural Heart, Vascular Tagged With: American Heart Assn.

Studies: After stroke, clot removal saves brain function

February 11, 2015 By MassDevice Contributors Network Leave a Comment

Studies: After stroke, clot removal saves brain function

(Reuters) – Grabbing and removing a clot blocking blood flow to the brain via thrombectomy, rather than just administering clot-busting drugs, dramatically improves the likelihood that patients will recover from a stroke, according to 2 highly-anticipated studies released today.

Filed Under: News Well Tagged With: American Heart Assn., American Stroke Assn., Clinical Trials, Covidien, International Stroke Conference, Penumbra Inc., Stroke, Stryker

  • Page 1
  • Page 2
  • Page 3
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy